These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32516417)

  • 21. Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage.
    Xu XR; Gallant RC; Ni H
    Thromb Res; 2016 May; 141 Suppl 2():S76-9. PubMed ID: 27207432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood platelets and thrombosis.
    Chatterjea JB
    J Indian Med Assoc; 1970 Jun; 54(11):516-8. PubMed ID: 5503459
    [No Abstract]   [Full Text] [Related]  

  • 23. A classification of disorders of hemostasis and thrombosis in patients with malignancy.
    Schmaier AH; Day HJ
    Prog Clin Biol Res; 1982; 89():1-20. PubMed ID: 7111293
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice.
    Verhenne S; Denorme F; Libbrecht S; Vandenbulcke A; Pareyn I; Deckmyn H; Lambrecht A; Nieswandt B; Kleinschnitz C; Vanhoorelbeke K; De Meyer SF
    Blood; 2015 Oct; 126(14):1715-22. PubMed ID: 26209660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets.
    Aburima A; Berger M; Spurgeon BEJ; Webb BA; Wraith KS; Febbraio M; Poole AW; Naseem KM
    Blood; 2021 Feb; 137(5):678-689. PubMed ID: 33538796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances of Studies on Platelet GPVI as Antithrombotic Target -Review].
    Li P; Qiao JL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):264-269. PubMed ID: 28245414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.
    Koupenova M; Clancy L; Corkrey HA; Freedman JE
    Circ Res; 2018 Jan; 122(2):337-351. PubMed ID: 29348254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice Expressing Low Levels of CalDAG-GEFI Exhibit Markedly Impaired Platelet Activation With Minor Impact on Hemostasis.
    Piatt R; Paul DS; Lee RH; McKenzie SE; Parise LV; Cowley DO; Cooley BC; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1838-46. PubMed ID: 27417588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report.
    Baig AA; Haining EJ; Geuss E; Beck S; Swieringa F; Wanitchakool P; Schuhmann MK; Stegner D; Kunzelmann K; Kleinschnitz C; Heemskerk JW; Braun A; Nieswandt B
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2152-2157. PubMed ID: 27634832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia.
    Marín Oyarzún CP; Glembotsky AC; Goette NP; Lev PR; De Luca G; Baroni Pietto MC; Moiraghi B; Castro Ríos MA; Vicente A; Marta RF; Schattner M; Heller PG
    Front Immunol; 2020; 11():705. PubMed ID: 32425934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interruption of thrombosis and hemostasis by anti-platelet agents.
    Shebuski RJ
    Toxicol Pathol; 1993; 21(2):180-9. PubMed ID: 8210940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial and blood interaction in haemostasis, thrombosis and atherogenesis.
    Bloom AL
    Haematologica; 1978 Apr; 63(2):101-24. PubMed ID: 98396
    [No Abstract]   [Full Text] [Related]  

  • 34. G13 is an essential mediator of platelet activation in hemostasis and thrombosis.
    Moers A; Nieswandt B; Massberg S; Wettschureck N; Grüner S; Konrad I; Schulte V; Aktas B; Gratacap MP; Simon MI; Gawaz M; Offermanns S
    Nat Med; 2003 Nov; 9(11):1418-22. PubMed ID: 14528298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood platelets and the elderly. Relation to the arterial wall and hemostasis].
    Boisseau MR
    Ann Cardiol Angeiol (Paris); 1991 May; 40(5):239-42. PubMed ID: 1859123
    [No Abstract]   [Full Text] [Related]  

  • 36. The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.
    Franchini M
    Methods Mol Biol; 2017; 1646():43-56. PubMed ID: 28804817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory Contribution of Platelets Revisited: New Players in the Arena of Inflammation.
    Chatterjee M; Geisler T
    Semin Thromb Hemost; 2016 Apr; 42(3):205-14. PubMed ID: 26886394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
    Zhang S; Zhang S; Hu L; Zhai L; Xue R; Ye J; Chen L; Cheng G; Mruk J; Kunapuli SP; Ding Z
    Circulation; 2015 Mar; 131(13):1160-70. PubMed ID: 25825396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.
    Klatt C; Krüger I; Zey S; Krott KJ; Spelleken M; Gowert NS; Oberhuber A; Pfaff L; Lückstädt W; Jurk K; Schaller M; Al-Hasani H; Schrader J; Massberg S; Stark K; Schelzig H; Kelm M; Elvers M
    J Clin Invest; 2018 Aug; 128(9):3906-3925. PubMed ID: 29952767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular interplay between platelets and the vascular wall in thrombosis and hemostasis.
    Berna-Erro A; Redondo PC; Lopez E; Albarran L; Rosado JA
    Curr Vasc Pharmacol; 2013 Jul; 11(4):409-30. PubMed ID: 23905637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.